Drug discontinuation: Travoprost Ophthalmic Solution (TRAVOPROST OPHTHALMIC SOLUTION, 0.004%)
FDA lists 2 presentations as To Be Discontinued. Companies: Mylan Pharmaceuticals Inc., a Viatris Company.
- Published by source
- 2026-07-07
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Mylan Pharmaceuticals Inc., a Viatris Company
- Products
- Travoprost Ophthalmic Solution TRAVOPROST OPHTHALMIC SOLUTION, 0.004%
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-07-07
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #1043 | new | 2026-10-22 | a3f4bc20ed79…d04ac3 | a1be79701fbf…d95586 |
Chain head: #1076 8ad5adc30b9b…88ce20